Company profile: Relypsa
1.1 - Company Overview
Company description
- Provider of biopharmaceutical research and development of non-absorbed polymeric drugs for cardiovascular and renal diseases, specializing in iron deficiency, nephrology, and cardio-renal therapies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Relypsa
Zewa
HQ: United States
Website
- Description: Provider of bluetooth products, pill boxes, scales, activity trackers, thermometers, pulse oximeters, and blood pressure monitors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zewa company profile →
Cardiva Medical
HQ: United States
Website
- Description: Provider of innovative vascular closure technology and devices to help the body heal after catheterization, including the VASCADE vascular closure system and Catalyst II and Catalyst III, which are designed to aid manual compression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiva Medical company profile →
Cardialen
HQ: United States
Website
- Description: Provider of pain-free cardioversion therapies for atrial fibrillation, developing implantable low-energy (low voltage) atrial cardioverters to address major unmet needs of this condition.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardialen company profile →
DalCor Pharmaceuticals
HQ: Canada
Website
- Description: Provider of pharmacogenetic precision treatments for cardiovascular disease targeting patients with the ADCY9 AA genotype, including dalcetrapib; the completed Dal-GenE (DAL-301) cardiovascular outcomes trial; the Phase 3 Dal-GenE-2 (DAL-302) trial evaluating dalcetrapib’s potential to reduce fatal and non-fatal myocardial infarction; and the cobas ADCY9 genotype companion diagnostic developed with Roche Molecular Systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DalCor Pharmaceuticals company profile →
Transcatheter Technologies
HQ: Germany
Website
- Description: Provider of a unique, repositionable transcatheter aortic valve implantation system designed to increase the safety and durability of aortic valve implantation. Its TRINITY transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Transcatheter Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Relypsa
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Relypsa
2.2 - Growth funds investing in similar companies to Relypsa
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Relypsa
4.2 - Public trading comparable groups for Relypsa
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →